William P. Batsford, M.D. Professor of Medicine (Cardiology)

B.S., Cornell University, 1965; M.D., Albany Medical College, 1969; Medical Residency, Hospital University of Pennsylvania 1969-1972; Research Fellow, USPHS, Staten Island, New York 1972-1974; Cardiology Fellow, Yale University 1974-1976; Joined Yale faculty, 1976.

Clinical/Research Interests:

Radiofrequency Ablation for SVT; Atrial Fib.; Ventricular Tachycardia; Pacemaker/ICD Therapy.


Lampert R, Jain D, Burg M, Batsford W, McPherson C. Destabilizing Effects of Mental Stress on Ventricular Arrhythmias in Patients With Implantable Cardioverter-Defibrillators. Circulation; 101(2):158-64, 2000.

Schreibman DS, Rosenfeld LE, McPherson CA, Patsford WP, Lampert R. Procainamide challenge significantly increases the yield of electrophysiologic testing for rish assessment without loss of positive value. J Am Cardiol; 39:117A, 2002.

Goldberger ZD, Rosenfeld LE, Batsford WP, McPherson CA, Lampert R. Combining clinical and electrophysiologic criteria effectively determines the need for dual chamber device in patients receiving implantable cardioverter defibrillators. PACE; 24:664, 2002.

Copyright © 2000, Yale University, New Haven, Connecticut, USA.
All rights reserved. Comments or suggestions to site editor.
Certifying authority:

Last modified: Friday, 12-Dec-2003 08:47:41 EST (PL).